ADAM17 is physiologically located at the cell membrane, in vesicles or in the cytoplasm, therefore we firstly investigated, if ADAM17 can be detected in cell culture supernatants as a result of active or passive release from ovarian cancer cells [29]. Here, ADAM17 is linked to ovarian carcinoma.